New Anemia Pill In The Works
Akebia and Fibrogen are both vying to treat chronic kidney disease patients—including dialyzors who suffer from anemia—with a pill. If approved, the drugs will take aim at replacing less convenient, injectable anemia drugs like Amgen's Epogen.
Read the full article » | Posted 01-10-2016
Related Articles
- Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
- Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026
- Meet the Dutch Neokidney: a New Suitcase Hemodialysis Machine Posted 01-16-2026
- Watch an AKF Webinar on Advancements in Home Dialysis Posted 12-17-2025

